Booth Andrew, Chief Financial Officer of AbCellera Biologics Inc. ($ABCL), made one open market purchase of ABCL shares in the last year, totaling about $146,000, with the most recent on February 27, 2026. This ranks him 1,852nd among nearly 5,000 insiders for purchase value, below the average of $1.46 million across 3.29 transactions per insider. He reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | AbCellera Biologics Inc. | $ABCL | Booth Andrew | Chief Financial Officer | P | Common Shares | 42600 | $3.42 | 326,559.0000 | 298,875,174 | 15.00% | 0.01% |
| Jan. 1, 2026 | AbCellera Biologics Inc. | $ABCL | Booth Andrew | Chief Financial Officer | A | Share option (right to buy) | 808898 | $0.00 | 8,751,849.0000 | 298,875,174 | 10.18% | 0.27% |
| Jan. 1, 2025 | AbCellera Biologics Inc. | $ABCL | Booth Andrew | Chief Financial Officer | A | Share option (right to buy) | 1352054 | $0.00 | 7,942,951.0000 | 294,327,532 | 20.51% | 0.46% |
| Jan. 14, 2024 | AbCellera Biologics Inc. | $ABCL | Booth Andrew | Chief Financial Officer | A | Share option (right to buy) | 770416 | $0.00 | 6,590,897.0000 | 289,166,486 | 13.24% | 0.27% |
| May 26, 2023 | AbCellera Biologics Inc. | $ABCL | Booth Andrew | Chief Financial Officer | P | Common Shares | 14500 | $6.85 | 283,959.0000 | 314,827,255 | 5.38% | 0.00% |